Keywords: ACA; Patient Protection and Affordable Care Act; IBD; inflammatory bowel disease; IBDSF; Inflammatory Bowel Disease Support Foundation; UCSD; University of California San Diego;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: IBD; inflammatory bowel disease; NGS; next-generation sequencing; rRNA; ribosomal RNA.; Human microbiome; Metagenomics; Microbiome dysbiosis; Next-generation sequencing;
Keywords: GADF; grape antioxidant dietary fibre; MIC; minimal inhibition concentration; DPPH; 2,2-diphenyl-1-picrylhydrazyl radical; DF; dietary fibre; SDF; soluble dietary fibre; TDF; total dietary fibre; IDF; insoluble dietary fibre; WGP; wine grape pomace; NEPAs
Keywords: CD; Crohn's disease; DPIN; Drug Program Information Network; IBD; Inflammatory bowel disease; LAI; Language arts achievement index; MAI; Mathematics achievement index; SEFI; Socioeconomic factor index; SES; Socioeconomic status; TNF; Tumor necrosis factor
Keywords: Gastrointestinal endoscopy; IBD; Inter-observer agreement; CIBDAI; Mucosal appearance;
Keywords: Mouse Model of IBD; Drug Delivery; TDDP; Technology; BL; budesonide liquid; BPL; budesonide polymer lipid; IBD; inflammatory bowel disease; TDDP; thermo-sensitive drug delivery platform;
Keywords: Inflammatory markers; M2-PK; Lactoferrin; Calprotectin; IBD
Keywords: Ulcerative Colitis; Infliximab; Accelerated Induction; AD; accelerated dosing; ASUC; acute severe ulcerative colitis; CRP; C-reactive protein; IBD; inflammatory bowel disease; IFX; infliximab; IQR; interquartile range; SD; standard dosing; TNF; tumor necr
Keywords: Ethnic Studies; Indian Immigrants; Lifestyle; Western; Latino; CD; Crohn's disease; CI; confidence interval; IBD; inflammatory bowel disease; OR; odds ratio; UC; ulcerative colitis;
Keywords: UC; CD; Complication; Comorbidity; CD; Crohn's disease; CI; confidence interval; CMV; cytomegalovirus; CS; corticosteroids; IBD; inflammatory bowel disease; IBDU; inflammatory bowel disease unclassified; IHC; immunohistochemistry; IM; immunomodulators;
Keywords: AES; acute encephalitis syndrome; AFP; acute flaccid paralysis; AMES; acute meningitis-encephalitis syndrome; BNG; Bangladesh; CHN; China; CSF; cerebrospinal fluid; ELISA; enzyme-linked immunosorbent assay; GFIMS; Global Framework for Immunization Monitor
Keywords: AID; autoimmune disorders; AF; adjuvant formulations; ASIA; autoimmune/inflammatory syndrome induced by adjuvants; CFA; complete Freundâ²s adjuvant; CIA; collagen-induced arthritis; DA; dark Agouti; DC; dendritic cells; EAE; experimental autoimmune encep
Keywords: Lactobacillus strains; PGN diversity; Anti-inflammatory capacity; HT-29 cells; RAW 264.7 cells; Peptidoglycan (PubChem CID: 9816401); N-acetylmuramic acid (PubChem CID: 12917652); N-acetylglucosamine (PubChem CID: 11861101); FITC (PubChem CID: 18730); DHB
Keywords: ALFSMN; axonal large-fiber sensorimotor neuropathy; ALFSN; axonal large-fiber sensory neuropathy; AMSP; acute motor sensory polyneuropathy; CD; Crohn's disease; CDSMP; chronic distal sensorimotor polyneuropathy; CIDP; chronic inflammatory demyelinating po
Keywords: CRC; colorectal cancer; GI; gastrointestinal; GWAS; genome wide association studies; IBD; inflammatory bowel disease;
Keywords: COX-2; cyclo-oxygenase-2; 5-FU; 5-fluorouracil; HE; hematoxylin and eosin; HQT; Huangqin Tang; HQTL; low dose of HQT extract with 1Â g/kg; HQTM; medium dose of HQT extract with 2Â g/kg; HQTH; high dose of HQT extract with 4Â g/kg; IBD; inflammatory bowel
Keywords: Colon Cancer; Inflammation; Screening; UC; BSG; British Society of Gastroenterology; CRC; colorectal cancer; DALM; dysplasia-associated lesion or mass; IBD; inflammatory bowel disease; PSC; primary sclerosing cholangitis; TNF; tumor necrosis factor;
Keywords: Crohn's Disease; Ulcerative Colitis; UC; CD; CI; confidence interval; EphMRA; European Pharmaceutical Market Research Association; GI; gastrointestinal; IBD; inflammatory bowel disease; ICD-9-CM; International Classification of Diseases, Ninth Revision,
Keywords: CD; Crohn's disease; DC; dendritic cell; IBD; inflammatory bowel disease; TLA1; TNF-like factor 1A; TREM-1; Triggering receptor expressed on myeloid cells-1; UC; ulcerative colitis; Inflammatory bowel disease; Intestinal microbiota; Mucosal tolerance; Mye
Keywords: angio; angiographic; AVM; arteriovenous malformation; CT; computerized tomography; d/c; discharge; ED; emergency department; endo; endoscopic; FFP; fresh frozen plasma; GIB; gastrointestinal bleeding; HR; hazard ratio; IBD; inflammatory bowel disease; ICU
Keywords: Colon; EMCG; Immune Response; Therapy; AZA; azathioprine; CC; collagenous colitis; IBD; inflammatory bowel disease; IEL; intraepithelial lymphocyte; IFN; interferon; LC; lymphocytic colitis; MC; microscopic colitis; QoL; quality of life; RCT; randomized c
Keywords: CD; Crohn's disease; IBD; Inflammatory bowel disease; IBD-U; IBD-unclassified; IL; Interleukin; PGA; Physician global assessment; PIBDCRG; Pediatric Inflammatory Bowel Disease Collaborative Research Group; UC; Ulcerative colitis; VEO; Very early-onset;
Keywords: TPP; therapeutic protein product; ADA; anti-drug antibody; mAb; monoclonal antibody; RA; rheumatoid arthritis; MS; multiple sclerosis; IBD; inflammatory bowel disease; NAb; neutralizing ADA; non-NAb; non-neutralizing ADA; PK; pharmacokinetics; PRCA; pure
Keywords: CVD; cardiovascular disease; CAD; coronary heart disease; PAH; pulmonary arterial hypertension; MIRI; myocardial ischemia-reperfusion injury; TGF-β; transforming growth factor-β; ICAM-1; intercellular adhesion molecule-1; VCAM-1; vascular cell adhesio
Keywords: CD; UC; Colon Cancer; Screening; Risk Factor; Early Detection; CD; Crohn's disease; CI; confidence interval; CRC; colorectal cancer; ESR; erythrocyte sedimentation rate; IBD; inflammatory bowel disease; OR; odds ratio; PSC; primary sclerosing cholangitis;
Keywords: Neoplasia; Thiopurines; Treatment; Cancer Risk Factor; ATC; Anatomical Therapeutic Chemical; CD; Crohn's disease; CI; confidence interval; HCD; hormonal contraceptive device; HPV; human papilloma virus; HSIL; high-grade squamous intraepithelial lesion;
Keywords: Type 1 immunity; type 2 immunity; type 3 immunity; innate lymphoid cells; TH1; TC1; TH2; TC2; TH17/TH22; TC17/TC22; APC; Antigen-presenting cell; CRTH2; Chemoattractant receptor-homologous molecule expressed on TH2 cells; DC; Dendritic cell; Eomes; Eomeso
Keywords: ASp; ankylosing spondylitis; CABG; coronary artery bypass grafting; CAD; coronary artery disease; CI; confidence interval; CKD; chronic kidney disease; DM; diabetes mellitus; ESRD; end-stage renal disease; HR; hazard ratio; IBD; inflammatory bowel disease
Keywords: CD; Crohn's disease; CDEIS; Crohn's disease endoscopic index of severity; CECDAI; Capsule Endoscopy Crohn's Disease Activity Index; DAE; device-assisted enteroscopy; IBD; inflammatory bowel disease; MaRIA; Magnetic Resonance Index of Activity; MH; m
Keywords: Hypersensitivity reactions; Drug allergy; Anaphylaxis; Biological agents; Monoclonal antibodies; Tryptase; Epinephrine; Skin testing; Rapid desensitization; AS; Ankylosing spondylitis; ASA; Acetylsalicylic acid; BAT; Basophil activation test; CD; Crohn's
Keywords: CD; Crohn's disease; CI; confidence interval; CRC; colorectal cancer; CRS; colorectal surgeon; HGD; high-grade dysplasia; IBD; inflammatory bowel disease; LGD; low-grade dysplasia; OR; odds ratio; PSC; primary sclerosing cholangitis; UC; ulcerative coli
Keywords: Delayed Diagnosis; Improving Outcomes; Surgery; Hospitalization; Medication Use; CD; Crohn's disease; CI; confidence interval; DPIN; Drug Program Information Network; GI; gastrointestinal; HCU; health care utilization; IBD; inflammatory bowel disease; M
Keywords: APRIL; A proliferation inducing ligand; BAFF; B cell activating factor; DCF; Chloromethyl-dichlorofluorescein diacetate; CD; Crohn's disease; Ct; Comparative threshold cycle; CON; Control; DHA; Docosahexaenoic acid; Cdh1; E cadherin; EPA; Eicosapentaeno
Keywords: LepRb; leptin receptor b; Th; T helper; Tconv cells; conventional T cells; Treg cells; regulatory T cells; mTOR; mammalian target of rapamycin; MS; multiple sclerosis; RRMS; relapsing-remitting multiple sclerosis; EAE; experimental autoimmune encephalomye
Keywords: AMK; Atractylodes macrocephala Koidz; PUT; putrescine; SPD; spermidine; SPE; spermine; TCM; traditional Chinese medicine; ODC; ornithine decarboxylase; UC; ulcerative colitis; CD; Crohn׳s disease; IBD; inflammatory bowel disease; Atractylodes macrocephal
Keywords: AFP; anal fistula plug; ECF; enterocutaneous fistula; ECM; extracellular matrix; IBD; inflammatory bowel disease; TPN; total parenteral nutrition; WV; wound vacuum;
Keywords: IBD; Inflammation; Myenteric Plexus; Enteric Glial Cells; 1400W; N-(3-aminomethyl) benzylacetamidine; cAMP; cyclic adenosine monophosphate; DSS; dextran sodium sulfate; EFS; electrical field stimulation; ENS; enteric nervous system; IBD; inflammatory bowe
Keywords: HIMEC; Human intestinal microvascular endothelial cells; HEMEC; Human esophageal microvascular endothelial cells; BRE; Black raspberry extract; IBD; Inflammatory bowel disease; CD; Crohn's disease; UC; Ulcerative colitis; CAM; Cell adhesion molecule; ICAM
Keywords: Serological biomarkers; IBD; 2D-DIGE; Diagnostics; Therapeutics;
Keywords: IBD; Treatment; Microbe; Colon; FMT; fecal microbial transplantation; UC; ulcerative colitis;
Keywords: Bacterial translocation; Cirrhosis; Hepatitis; Liver diseases; Microbiota; Probiotics; GI; gastrointestinal; BECs; biliary epithelial cells; TLRs; Toll-like receptors; IL; interleukin; TNF; tumor necrosis factor; LPS; lipopolysaccharide; NF-κβ; nuclear
Keywords: AEA; arachidonoyl ethanolamide; 2-AG; 2-arachidonoylglycerol; ARA; arachidonic acid; CB; endocannabinoid receptor; COX; cyclooxygenase; DHA; docosahexaenoic acid; DP; prostaglandin D receptor; DPA; docosapentaenoic acid; EP; prostaglandin E receptor; EPA;
Keywords: Network Meta-analysis; IBD; Anti-TNF Therapy; Immunosuppressive Agents; CDAI; Crohn's Disease Activity Index; CrI; credible interval; OR; odds ratio; TNF; tumor necrosis factor; WDAE; withdrawals due to adverse events;
Keywords: APC; antigen presenting cell; BCG; Bacillus Calmette-Guérin; cAMP; cyclic adenosine monophosphate; CDCA; chenodeoxycholic acid; CFA; colonisation factor antigen; CMCE; carboxymethylethylcellulose; CSR; class switch recombination; CT; cholera toxin; CTA
Keywords: GETAID Study; CD; UC; Colon Cancer Risk Factors; Carcinogenesis; CD; Crohn's disease; GETAID; Groupe d'études et thérapeutiques des affections inflammatoires du tube digestif; HGD; high-grade dysplasia; IBD; inflammatory bowel disease; IBD-U; undete
Keywords: Ulcerative Colitis; 5-Aminosalicylate; Corticosteroid; Thiopurine; Anti-Tumor Necrosis Factor; Vedolizumab; Probiotics; ADA; antidrug antibodies; CAG; Canadian Association of Gastroenterology; CI; confidence interval; FMT; fecal microbial transplant; GR
Keywords: Treatment; Complication; Death; Survival; CD; Crohn's disease; CI; confidence interval; IBD; inflammatory bowel disease; TNF; tumor necrosis factor; UC; ulcerative colitis;
Keywords: BCS; Biopharmaceutics Classification System; ConA; concanavalin A; GI; gastrointestinal; IBD; inflammatory bowel disease; IBS; irritable bowel syndrome; MEMS; microelectromechanical systems; MIMIC; micromolding in capillaries; MIPs; molecularly imprinted
Keywords: IBD; Immune Suppression; Clinical Trial; Inflammatory Bowel Disease; ACCENT; A Crohn's Disease Clinical Trial Evaluating Infliximab in a New Long-term Treatment Regimen; CDAI; Crohn's Disease Activity Index; CI; confidence interval; IM; immunomodulator;
Keywords: IBD; Clinical Trial; Inflammatory Bowel Disease; Phytochemical; CI; confidence interval; OR; odds ratio; SCCAI; Simple Clinical Colitis Activity Index; UC; ulcerative colitis;